Fundz

Jnana Therapeutics Closes $50 Million Series B Financing To Advance Lead Pku Program And Small Molecule Pipeline Based On Next Gen Chemoproteomic Platform

PRIVATEAug 18, 2021

Amount Raised

$50 Million

Round Type

Series B

BostonBiotechnologyHealth CareTransportation

Description

Jnana Therapeutics, a biotechnology company utilizing its next generation chemoproteomic platform to target SLC transporters and other well-validated but hard-to-drug targets, today announced the closing of a $50 million Series B financing. The financing was led by RA Capital Management, and included all existing investors, including Polaris Partners, Versant Ventures, Avalon Ventures, AbbVie Ventures and Pfizer Ventures.

Quick answer

Jnana Therapeutics Inc. raised $50 Million in a Series B round, dated August 18, 2021. Jnana Therapeutics Inc. is based in Boston, Massachusetts, United States.

How much did Jnana Therapeutics Inc. raise?
Jnana Therapeutics Inc. raised $50 Million in a Series B round on August 18, 2021.
What does Jnana Therapeutics Inc. do?
Jnana Therapeutics is a clinical-stage biotechnology company leveraging its next-generation chemoproteomics RAPID platform to discover medicines for highly validated, challenging-to-drug targets to treat diseases with..
Where is Jnana Therapeutics Inc. based and how big is it?
Jnana Therapeutics Inc. is based in Boston, Massachusetts, United States.
Who are the decision-makers at Jnana Therapeutics Inc?
Fundz holds 1 contact at Jnana Therapeutics Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Transportation and Biotechnology around the same time

Companies in the same sectors as Jnana Therapeutics Inc. that raised within 45 days of this round, from Fundz verified event records.

  • PMGC Holdings Inc. raised $732K (Seed) on October 1, 2021.
  • PMGC Holdings Inc. raised $139K (Pre-Seed) on October 1, 2021.
  • Envisagenics raised an undisclosed amount (Series A) on September 29, 2021.
  • TriSalus Life Sciences raised $24M on September 29, 2021.
  • Athos Therapeutics, Inc. raised $13M on September 28, 2021.
  • Life Biosciences raised an undisclosed amount (Funding Round) on September 28, 2021.

Who to call at Jnana Therapeutics Inc., and when

A new round usually means Jnana Therapeutics Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Jnana Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Jnana Therapeutics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Jnana Therapeutics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Jnana Therapeutics Inc.

Location

6 Tide Street

Boston, Massachusetts, United States

About

Jnana Therapeutics is a clinical-stage biotechnology company leveraging its next-generation chemoproteomics RAPID platform to discover medicines for highly validated, challenging-to-drug targets to treat diseases with high unmet need. Jnana is focused on developing first- and best-in-class therapies to treat a wide range of diseases, including rare diseases, immune-mediated diseases and cancer. Jnana’s wholly owned lead program is a potential first-in-class oral approach, targeting an allosteric site on the phenylalanine transporter SLC6A19, for the treatment of phenylketonuria (PKU), a rare genetic metabolic disease. Located in Boston, Jnana brings together scientific leaders in small molecule drug discovery and development, a highly experienced management team and the backing of leading life science investors Bain Capital Life Sciences, RA Capital Management, Polaris Partners, Versant Ventures, Avalon Ventures, Pfizer Ventures and AbbVie Ventures.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Jnana Therapeutics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Jnana Therapeutics Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Jnana Therapeutics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.